THERAPEUTIC ME INDICATION | PROPHYLACTIC ME INDICATION | ||||
---|---|---|---|---|---|
NO IBLR/NP (DF cohort) | WITH IBLR/NP (D-cohort) | p-VALUE | NO IBLR/NP (DF-cohort) | WITH IBLR/NP (D-cohort) | |
Whole breast volume (median cm3, IQR) a | 615.80 (409.90; 851.10) | 455.00 (250.20; 814.00) | .169 | 388.40 (217.10; 632.850) | NA |
Fibroglandular tissue (FGT) | |||||
- Volume (median cm3, IQR) | 69.950 (33.68; 128.10) | 40.255 (196.10; 139.70) | .351 | 50.31 (34.485; 78.565) | NA |
Residual fibroglandular tissue (RFGT) | |||||
- Medial (median mm, IQR) | 0 (0; 1.0) | 2.0 (1.0; 2.0) | .003 | 0 (0; 2.0) | NA |
- Lateral (median mm, IQR) | 1.0 (0; 3.0) | 1.0 (1.0; 2.0) | .910 | 2.0 (1.0; 3.0) | NA |
- Retroareolar (median mm, IQR) | 1.0 (0; 2.0) | 4.0 (3.0; 5.0) | .029 | 2.0 (0; 4.0) | NA |
- Volume (median mm3, IQR) | 155.0 (20.0; 1779.5) | 1776.5 (107.0; 3152.0) | .017 | 693.50 (50.0; 2970.0) | 100.0 |